American Vietnamese Biotech (HSTC:AMV) Debt-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

American Vietnamese Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's annualized Revenue for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech Debt-to-Revenue Historical Data

The historical data trend for American Vietnamese Biotech's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Debt-to-Revenue Chart

American Vietnamese Biotech Annual Data

Trend

Debt-to-Revenue

American Vietnamese Biotech Quarterly Data

Debt-to-Revenue

Competitive Comparison of American Vietnamese Biotech's Debt-to-Revenue

For the Biotechnology subindustry, American Vietnamese Biotech's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Vietnamese Biotech's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Debt-to-Revenue falls into.

American Vietnamese Biotech Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

American Vietnamese Biotech's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	N/A
	=	N/A

American Vietnamese Biotech's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(	+	)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (. 20) Revenue data.

American Vietnamese Biotech Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM

Website

http://www.amvibiotech.com

American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.